We are live on
!
Find out more
Immunic
IMUX
IMUX
72 hedge funds and large institutions have $63.4M invested in Immunic in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more call options, than puts
Call options by funds: $3.66M | Put options by funds: $2.56M
0.33% less ownership
Funds ownership: 6.31% → 5.98% (-0.33%)
10% less funds holding
Funds holding: 80 → 72 (-8)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 26
68% less capital invested
Capital invested by funds: $198M → $63.4M (-$135M)
Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
16
Reduced
26
Closed
24
Calls
$3.66M
Puts
$2.56M
Net Calls
+$1.1M
Net Calls Change
-$2.7M
Top Buyers
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$7.08M |
| 2 |
Millennium Management
New York
|
+$3.94M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.85M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.84M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$3.27M |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.59M |
| 2 |
BlackRock
New York
|
-$5.4M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$4.38M |
| 4 |
ACM
Altium Capital Management
New York
|
-$3.39M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.81M |
